MA28284A1 - Nitro-oxydérivés de prostaglandines - Google Patents

Nitro-oxydérivés de prostaglandines

Info

Publication number
MA28284A1
MA28284A1 MA29169A MA29169A MA28284A1 MA 28284 A1 MA28284 A1 MA 28284A1 MA 29169 A MA29169 A MA 29169A MA 29169 A MA29169 A MA 29169A MA 28284 A1 MA28284 A1 MA 28284A1
Authority
MA
Morocco
Prior art keywords
prostaglandins
nitro
oxidized
oxyderivated
nicox
Prior art date
Application number
MA29169A
Other languages
English (en)
Inventor
Ennio Ongini
Francesca Benedini
Valerio Chiroli
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34778199&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28284(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of MA28284A1 publication Critical patent/MA28284A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

DEPOSANT Société dite : NICOX, S.A. REVENDICATION DE PRIORITES EP 5 Janvier 2004 04100001.9 Voir en annexe le titre de l'invention et le texte de l'abrégé Nitro-oxydérivés de prostaglandines Des nitro-oxyderivés de prostaglandines ayant une activité pharmacologique améliorée et une capacité de tolérance accrue sont décrits. Ils peuvent être utilisés pour le traitement du glaucome et de l'hypertension oculaire.
MA29169A 2004-01-05 2006-07-05 Nitro-oxydérivés de prostaglandines MA28284A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04100001 2004-01-05

Publications (1)

Publication Number Publication Date
MA28284A1 true MA28284A1 (fr) 2006-11-01

Family

ID=34778199

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29169A MA28284A1 (fr) 2004-01-05 2006-07-05 Nitro-oxydérivés de prostaglandines

Country Status (39)

Country Link
US (5) US7273946B2 (fr)
EP (3) EP3643702A1 (fr)
JP (1) JP3984283B2 (fr)
KR (2) KR100854838B1 (fr)
CN (1) CN100469765C (fr)
AP (1) AP2006003638A0 (fr)
AR (2) AR047081A1 (fr)
AU (1) AU2004313688B2 (fr)
BR (1) BRPI0418245B8 (fr)
CA (1) CA2551409C (fr)
CR (2) CR8498A (fr)
CY (1) CY1117417T1 (fr)
DK (1) DK1704141T3 (fr)
EA (1) EA010595B1 (fr)
EC (1) ECSP066684A (fr)
ES (2) ES2767136T3 (fr)
GE (1) GEP20094780B (fr)
GT (1) GT200500293A (fr)
HR (1) HRP20160500T1 (fr)
HU (1) HUE027357T2 (fr)
IL (1) IL176416A (fr)
MA (1) MA28284A1 (fr)
ME (1) ME02433B (fr)
MX (1) MXPA06007678A (fr)
MY (1) MY147181A (fr)
NO (2) NO337217B1 (fr)
NZ (1) NZ548271A (fr)
OA (1) OA13356A (fr)
PA (1) PA8620901A1 (fr)
PE (1) PE20051052A1 (fr)
PL (1) PL1704141T3 (fr)
RS (1) RS54717B1 (fr)
SI (1) SI1704141T1 (fr)
TN (1) TNSN06210A1 (fr)
TW (1) TWI337994B (fr)
UA (1) UA84726C2 (fr)
UY (1) UY28709A1 (fr)
WO (1) WO2005068421A1 (fr)
ZA (1) ZA200605354B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2767136T3 (es) 2004-01-05 2020-06-16 Nicox Sa Derivados de prostaglandinas
JP2009500315A (ja) * 2005-06-29 2009-01-08 ファイザー・インク フルオロプロスタグランジンのニトロ誘導体
EP1899295A2 (fr) * 2005-06-29 2008-03-19 Pfizer, Inc. Derives de prostaglandine
CA2647859C (fr) * 2006-03-29 2016-01-05 Nitromed, Inc. Prostaglandines amplificatrices d'oxyde nitrique, compositions et methodes d'utilisation
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
DE102006052755A1 (de) * 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren
WO2008071421A1 (fr) * 2006-12-15 2008-06-19 Nicox S.A. Esters de l'acide nitrique des inhibiteurs d'anhydrase carbonique
US20100063035A1 (en) 2006-12-15 2010-03-11 Nicox S.A. Carbonic anhydrase inhibitors derivatives
WO2008149181A1 (fr) 2007-06-04 2008-12-11 Techfields Inc Promédicaments d'ains à vitesse de pénétration cutanée et membranaire très élevée et leurs nouvelles utilisations médicales
WO2009035565A1 (fr) * 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Analogues de prostaglandines pour des dispositifs d'implant et procédés
EP2214482A4 (fr) * 2007-10-31 2011-08-24 Pamela Lipkin Compositions d'analogues de prostaglandine et procédés de traitement d'états épithéliaux
AR076731A1 (es) * 2008-05-09 2011-07-06 Pfizer Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas
US7807716B2 (en) * 2008-09-24 2010-10-05 Oral Delivery Technology Ltd. Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
KR101172638B1 (ko) 2008-12-30 2012-08-08 조선대학교산학협력단 신규한 티아졸리딘디온 유도체 및 그의 용도
CN102498088A (zh) * 2009-09-15 2012-06-13 帝斯曼知识产权资产管理有限公司 硝基氧基酯及其制备和用途
CN101885684B (zh) * 2010-07-01 2013-10-30 南京中医药大学 带有一氧化氮供体的芳香酸前体药物及其制备方法和其应用
ES2727203T3 (es) 2011-08-29 2019-10-14 Mati Therapeutics Inc Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
CA2872338C (fr) 2012-05-03 2021-09-14 Qlt Inc. Systeme d'administration de medicament et procedes de traitement d'un glaucome a angle ouvert et de l'hypertension oculaire
US9446015B2 (en) * 2012-10-23 2016-09-20 Nicox Science Ireland Quinone based nitric oxide donating compounds for ophthalmic use
JP6306148B2 (ja) * 2013-04-18 2018-04-04 ニコックス サイエンス アイルランド 点眼用のキノン系一酸化窒素供与性化合物
EP3091985B1 (fr) 2014-01-10 2024-05-08 Manistee Therapeutics, Inc. Prostanglandines pour leur utilisation topique dans le traitement des migraines.
CA2964364A1 (fr) * 2014-10-15 2016-04-21 Novartis Ag Conjugues et derives de prostaglandine pour traitement du glaucome et de l'hypertension oculaire
WO2016155906A1 (fr) * 2015-03-31 2016-10-06 Nicox S.A. Dérivés de fluprosténol donneurs d'oxyde nitrique
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
EP3088388A1 (fr) 2015-04-30 2016-11-02 NicOx S.A. Dérivés de prostaglandines donneurs d'oxyde nitrique
EA037327B1 (ru) 2015-09-22 2021-03-12 Грейбуг Вижн, Инк. Соединения и композиции для лечения глазных расстройств
HU231175B1 (hu) * 2015-12-04 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Tetszőleges, előre meghatározott minőségű Latanoprostene bunod előállítása gravitációs kromatográfiával
CA3043000A1 (fr) 2016-11-08 2018-05-17 Bausch & Lomb Incorporated Derives de prostaglandine liberant de l'oxyde nitrique pour le traitement du glaucome a tension normale
KR102069205B1 (ko) * 2017-08-09 2020-01-22 연성정밀화학(주) 라타노프로스틴 부노드의 제조 방법 및 그를 위한 중간체
RU2718744C2 (ru) * 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
CN109988089B (zh) * 2018-05-29 2022-04-26 上海凡秦医药科技有限公司 一种前列腺素化合物、制备方法及其用途
CN108892624B (zh) * 2018-06-20 2020-12-15 重庆威鹏药业有限公司 沙库巴曲硝基氧衍生物及其制备方法和应用
ES2964005T3 (es) * 2019-08-05 2024-04-03 Nicox Sa Procedimiento de preparación de un análogo de prostaglandina donador de óxido nítrico
US11332433B2 (en) 2020-07-24 2022-05-17 Chirogate International Inc. Process for the preparation of latanoprostene bunod and intermediate thereof and compositions comprising the same
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
CN116444377A (zh) * 2022-01-07 2023-07-18 广州楷石医药有限公司 一种氧化氮供体型曲前列尼尔类衍生物及其药物组合物和用途
CA3195291A1 (fr) * 2022-04-13 2023-10-13 Caravel Therapeutics, Inc. Emulsion pharmaceutique ophtalmique sans preservatif et application connexe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922293A (en) 1971-12-30 1975-11-25 Upjohn Co Prostaglandin F-type 9-monoacylates
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
EP1348437A3 (fr) 1988-09-06 2003-11-19 Pharmacia Aktiebolag Dérivés de prostaglandine pour le traitement du glaucome ou de l'hypertension oculaire
DE69311361T2 (de) 1992-10-13 1998-01-08 Alcon Lab Inc Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
US5625083A (en) * 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1292377B1 (it) * 1997-06-19 1999-02-08 Nicox Sa Composizioni farmaceutiche a base di prostaglandine
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
US20030018079A1 (en) 2000-11-13 2003-01-23 Richardson Helene Treatment
BR0209063A (pt) * 2001-04-19 2004-08-10 Teika Pharmaceutical Co Ltd Medicamentos e kits de uso medicinal
ES2767136T3 (es) 2004-01-05 2020-06-16 Nicox Sa Derivados de prostaglandinas

Also Published As

Publication number Publication date
NZ548271A (en) 2010-01-29
ES2767136T3 (es) 2020-06-16
UY28709A1 (es) 2005-08-31
CR20110131A (es) 2011-03-30
SI1704141T1 (sl) 2016-04-29
JP3984283B2 (ja) 2007-10-03
US20100130507A1 (en) 2010-05-27
BRPI0418245A (pt) 2007-04-17
TNSN06210A1 (fr) 2007-12-03
HRP20160500T1 (hr) 2016-06-03
EP3002277A1 (fr) 2016-04-06
WO2005068421A1 (fr) 2005-07-28
NO20151341A1 (no) 2006-09-07
ME02433B (fr) 2016-09-20
BRPI0418245B8 (pt) 2021-05-25
MXPA06007678A (es) 2006-09-01
AU2004313688B2 (en) 2010-08-05
BRPI0418245B1 (pt) 2017-05-30
TW200526567A (en) 2005-08-16
EA200601099A1 (ru) 2006-10-27
DK1704141T3 (en) 2016-05-02
ES2566800T3 (es) 2016-04-15
EP3643702A1 (fr) 2020-04-29
US7273946B2 (en) 2007-09-25
ZA200605354B (en) 2009-09-30
MY147181A (en) 2012-11-14
EA010595B1 (ru) 2008-10-30
EP1704141A1 (fr) 2006-09-27
CA2551409A1 (fr) 2005-07-28
US20110136904A1 (en) 2011-06-09
ECSP066684A (es) 2006-10-25
KR100854838B1 (ko) 2008-08-29
US7629345B2 (en) 2009-12-08
PA8620901A1 (es) 2005-08-30
GT200500293A (es) 2007-07-06
OA13356A (en) 2007-04-13
HK1096084A1 (zh) 2007-05-25
EP3002277B1 (fr) 2019-11-06
PE20051052A1 (es) 2005-12-17
EP1704141B1 (fr) 2016-02-24
AP2006003638A0 (en) 2006-06-30
AR047081A1 (es) 2006-01-04
IL176416A (en) 2013-05-30
GEP20094780B (en) 2009-09-25
US20090030076A1 (en) 2009-01-29
AU2004313688A1 (en) 2005-07-28
CN100469765C (zh) 2009-03-18
US20050272743A1 (en) 2005-12-08
RS54717B1 (sr) 2016-08-31
NO20063567L (no) 2006-09-07
JP2007518716A (ja) 2007-07-12
KR20080007415A (ko) 2008-01-18
NO337217B1 (no) 2016-02-15
US7449469B2 (en) 2008-11-11
CR8498A (es) 2006-11-15
KR100850133B1 (ko) 2008-08-04
KR20060113753A (ko) 2006-11-02
UA84726C2 (ru) 2008-11-25
CY1117417T1 (el) 2017-04-26
US20080058392A1 (en) 2008-03-06
CN1906159A (zh) 2007-01-31
IL176416A0 (en) 2006-10-05
WO2005068421A8 (fr) 2006-02-09
US7910767B2 (en) 2011-03-22
PL1704141T3 (pl) 2016-08-31
US8058467B2 (en) 2011-11-15
NO339685B1 (no) 2017-01-23
TWI337994B (en) 2011-03-01
HUE027357T2 (en) 2016-09-28
CA2551409C (fr) 2011-02-22
AR098931A2 (es) 2016-06-22

Similar Documents

Publication Publication Date Title
MA28303A1 (fr) Derives de sulfonamides pour le traitement de maladies
MA27190A1 (fr) Derives de tropane servant de modulateurs de ccr5
MA28003A1 (fr) [1,8] naphtyridine-2-ones et composes apparentes pour le traitement de la schizophrenie
GEP20094780B (en) Prostaglandin nitrooxyderivatives
PH12012500809A1 (en) Methods and compositions for treating cancer
DK1646389T3 (da) Pyrimidin-2,4-dionderivater som gonadotropinfrigörende hormonreceptorantagonister
EP2100903A3 (fr) Anticorps anti-idiotypiques neutralisant l'activité inhibitrice d'un anticorps inhibiteur dirigé contre le domaine C1 du facteur VIII
EA200800727A1 (ru) Введение ингибиторов дипептидилпептидазы
PL1843789T3 (pl) Kompozycje i sposoby leczenia zaburzeń zwłóknieniowych
TW200700406A (en) Novel thiophene derivatives
ATE384050T1 (de) Benzazepinderivate als histamin-h3-antagonisten
MA33053B1 (fr) Inhibiteurs de la poly(adp-ribose) polymerase (parp)
MY147949A (en) Hydrogenated benzo[c]thiophene derivatives as immunomodulators
MA31821B1 (fr) Anticorps anti-cxcr5 humanises, leurs derives et leurs utilisations
TW200716552A (en) Novel thiophene derivatives
ATE430746T1 (de) Crf-rezeptor-antagonisten und zugehörige verfahren
EA200601841A1 (ru) Композиции, содержащие ингибитор jnk и циклоспорин
DE602005023197D1 (de) -muscarinrezeptors
ATE433966T1 (de) Methylendipiperidinderivate
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
GB0320320D0 (en) Novel compounds
WO2006071775A3 (fr) Composes utiles pour l'antagonisme du recepteur b1 de la bradykinine
MA29910B1 (fr) Potentialisateurs des recepteurs ampa
MX2007006754A (es) Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos.
MX2010004314A (es) Compuestos para inhibir la actividad de quinesina de la proteina quinesina del huso.